Form D Explorer

Form C-AR — Deverra Therapeutics, Inc.

0001665160-25-000587 · filed 2025-04-10

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
1822782
Entity
Corporation
Jurisdiction
DE
Address
1600 Fairview Ave E STE 300
Seattle, WA 98102
Phone

Most recent fiscal year financials

Total assets
$11,309,048
Cash
Short-term debt
$1,690,073
Long-term debt
Revenues
$3,879,188
COGS
$3,879,188
Taxes paid
Net income
$-3,718,064

View original on SEC EDGAR.